General Information of Drug (ID: DMLI9U6)

Drug Name
AVI-7537 Drug Info
Indication
Disease Entry ICD 11 Status REF
Ebola virus infection 1D60.0 Phase 1 [1]
Cross-matching ID
TTD Drug ID
DMLI9U6

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
AVI-6002 DMVUW8A Ebola virus infection 1D60.0 Phase 1 [2]
AVI-6003 DMIJSDO Marburg virus infection 1D60.1 Phase 1 [2]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Ebola virus VP24 messenger RNA (EV VP24 mRNA) TTDJLWQ VP24_EBOSU Not Available [2]

References

1 ClinicalTrials.gov (NCT01593072) A Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-7537 in Healthy Adult Volunteers. U.S. National Institutes of Health.
2 Discovery and Early Development of AVI-7537 and AVI-7288 for the Treatment of Ebola Virus and Marburg Virus Infections. Viruses. 2012 November; 4(11): 2806-2830.